Theravance Biopharma, Inc. · NASDAQ:TBPH

O'Connor Donal disposed of 80,213 Theravance Biopharma, Inc. shares (Form 4)

Traded Sep 23, 2026 · Filed Sep 24, 2026

On Sep 23, 2026, O'Connor Donal (Director) disposed of 80,213 Theravance Biopharma, Inc. shares, leaving 0 shares. Filed Sep 24, 2026 (Form 4).

Disposed of
80,213 shares
Holding after
0 shares
Trading plan
No
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 23, 2026Ordinary SharesDisposition74,2046,009Direct
Sep 23, 2026Ordinary SharesDisposition6,0090Direct

Source

View original at SEC

Related